Veterinary Medicine and Science (Jul 2024)

Prognostic role of the updated Kiel classification in canine high‐grade T‐cell lymphomas

  • Urszula Jankowska,
  • Dariusz Jagielski,
  • Michał Czopowicz,
  • Rafał Sapierzyński

DOI
https://doi.org/10.1002/vms3.1398
Journal volume & issue
Vol. 10, no. 4
pp. n/a – n/a

Abstract

Read online

Abstract Background The aim of this study was to determine and describe the prognostic role of the morphological subtype determined according to the updated Kiel classification in dogs with high‐grade T‐cell lymphomas (HGTCLs) depending on the treatment applied. Objectives The HGTCLs were classified into three subtypes according to the updated Kiel classification: pleomorphic mixed (PM), lymphoblastic lymphoma/acute lymphoblastic leukaemia and plasmacytoid (P). The treatment was divided into a palliative therapy (PlT) group and a chemotherapy (ChT) group. Methods The study was conducted between 2009 and 2017, and it enrolled 58 dogs in which cytomorphological and immunocytochemistry diagnoses were HGTCL. Results Overall survival (OS) was significantly longer in the ChT group (median OS—4 months, interquartile range [IQR] from 2 to 8 months) than in the PlT group (median OS—6 weeks, IQR from 1 week to 3 months). In the PlT group, PM subtype and glucocorticosteroids (GCSs) treatment proved significantly and independently linked to longer OS and approximately three‐fold lower risk of death during the study period (adjusted hazard ratio [HRadj] = 0.26, confidence interval [CI] 95%: 0.08–0.81; p = 0.020 and HRadj = 0.30, CI 95%: 0.11–0.77; p = 0.013, respectively), although due to small group size, precision of estimations was poor (wide CI 95%). In the ChT group, >7 days elapsing between diagnosis and the beginning of chemotherapy and GCS treatment prior to chemotherapy were significantly associated with lower chance of complete remission (CR; p = 0.034 for both); GCS treatment prior to chemotherapy was significantly associated with shorter OS (p = 0.016); chemotherapy based on the modified CHOP protocol was significantly associated with higher chance of CR (p = 0.034) and longer OS (p = 0.039); and CR was significantly linked to longer OS (p = 0.001). Clinical significance The morphological subtype of HGTCL has some prognostic value in dogs treated palliatively (with PM subtype associated with longer OS than P subtype); however, this effect is no longer visible when a dog is treated with chemotherapy.

Keywords